Balyasny Asset Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$524K Buy
+55,717
New +$499K ﹤0.01% 2344
2025
Q4
Sell
-13,645
Closed -$194K 3127
2025
Q3
$194K Buy
+13,645
New +$180K ﹤0.01% 2731
2025
Q1
Sell
-30,152
Closed -$548K 2836
2024
Q4
$548K Buy
+30,152
New +$406K ﹤0.01% 2167
2024
Q1
Sell
-26,947
Closed -$610K 2655
2023
Q4
$610K Buy
+26,947
New +$584K ﹤0.01% 1867
2023
Q3
Sell
-478,620
Closed -$13.4M 2295
2023
Q2
$13.4M Buy
+478,620
New +$11.9M 0.03% 661
2023
Q1
Sell
-24,126
Closed -$641K 2694
2022
Q4
$641K Buy
24,126
+14,660
+155% +$478K ﹤0.01% 1797
2022
Q3
$269K Sell
9,466
-85,254
-90% -$2.19M ﹤0.01% 2226
2022
Q2
$1.97M Sell
94,720
-169,859
-64% -$3.18M 0.01% 1407
2022
Q1
$5.73M Sell
264,579
-99,440
-27% -$2.16M 0.02% 895
2021
Q4
$10.1M Buy
364,019
+88,040
+32% +$2.13M 0.03% 630
2021
Q3
$5.86M Buy
+275,979
New +$5.18M 0.02% 767
2020
Q2
Sell
-143,542
Closed -$967K 1157
2020
Q1
$967K Buy
+143,542
New +$1.36M 0.01% 768
2019
Q4
Sell
-83,808
Closed -$863K 1181
2019
Q3
$863K Buy
+83,808
New +$824K 0.01% 861
2017
Q4
Sell
-20,172
Closed -$287K 2074
2017
Q3
$287K Buy
+20,172
New +$253K ﹤0.01% 1553

Other funds holding CCRN

Balyasny Asset Management's CCRN Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Cross Country Healthcare (CCRN) in Q1 2026: 55,717 shares worth $524K. The stake represents ﹤0.01% of the portfolio and ranks #2344 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in CCRN as recently as Q3 2025.

Balyasny Asset Management first reported a position in CCRN in Q3 2017 and has held it in 14 quarters since. The position peaked at $13.4M in Q2 2023. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Balyasny Asset Management held 55,717 shares of Cross Country Healthcare worth $524K as of Q1 2026.
  • Cross Country Healthcare was a new Balyasny Asset Management position in Q1 2026.
  • Cross Country Healthcare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2344 holding.
  • Balyasny Asset Management first reported a position in Cross Country Healthcare in Q3 2017 and has held it in 14 quarters since.
  • Balyasny Asset Management's Cross Country Healthcare position peaked at $13.4M in Q2 2023.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.